Sec Form 13G Filing - Theofilos Charles Steve filing for - 2025-07-09

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The shares reported in rows 6, 8 and 9 above include 85,973 shares of Common Stock held in a joint account between Charles Theofilos and Kathryn Theofilos. The percentage in row 11 above is based on 7,420,618 shares of Common Stock outstanding as of May 2, 2025, as described in the Issuer's Form 10-Q filed with the SEC on May 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The shares reported in rows 6, 8 and 9 above include (i) 85,973 shares of Common Stock held in a joint account between Charles Theofilos and Kathryn Theofilos, (ii) 153,168 shares of Common Stock held by Happy Holstein, LLLP, of which Happy Holstein Management, LLC (HH Management) is the general partner, of which Kathryn Theofilos is the manager, (iii) 790 shares of Common Stock held by MCKT, LLC, a Florida limited liability company of which Kathryn Theofilos is the manager, and (iv) 150,000 shares of Common Stock issuable upon exercise of presently exercisable warrants held by HH Management. Excludes 1,401,777 shares of Common Stock issuable upon exercise of warrants held by HH Management due to a 9.99% beneficial ownership limitation. See Item 4 for more information regarding the warrants and beneficial ownership limitations. The percentage in row 11 above is based on (i) 7,420,618 shares of Common Stock outstanding as of May 2, 2025, as described in the issuer's Form 10-Q filed with the SEC on May 7, 2025 and (ii) 150,000 shares of Common Stock issuable upon exercise of presently exercisable warrants held by HH Management.


SCHEDULE 13G



Comment for Type of Reporting Person:  The shares reported in rows 6, 8 and 9 above include (i) 153,168 shares of Common Stock held by HH Management and (ii) 150,000 shares of Common Stock issuable upon exercise of presently exercisable warrants held by HH Management. Excludes 1,401,777 shares of Common Stock issuable upon exercise of warrants held by HH Management due to a 9.99% beneficial ownership limitation. See Item 4 for more information regarding the warrants and beneficial ownership limitations. The percentage in row 11 above is based on (i) 7,420,618 shares of Common Stock outstanding as of May 2, 2025, as described in the issuer's Form 10-Q filed with the SEC on May 7, 2025 and (ii) 150,000 shares of Common Stock issuable upon exercise of presently exercisable warrants held by HH Management.


SCHEDULE 13G


 
Theofilos Charles Steve
 
Signature:/s/ Charles Theofilos
Name/Title:Charles Theofilos
Date:07/09/2025
 
Kathryn Theofilos
 
Signature:/s/ Kathryn Theofilos
Name/Title:Kathryn Theofilos
Date:07/09/2025
 
Happy Holstein Management, LLC
 
Signature:/s/ Kathryn Theofilos
Name/Title:Kathryn Theofilos, Manager
Date:07/09/2025
Exhibit Information

Form of 2023 Pre-funded Warrant (incorporated by reference to Exhibit 4.1 to the Form 8-K filed by the issuer on July 31, 2023: https://www.sec.gov/Archives/edgar/data/1560258/000119380523001031/e618813_ex4-1.htm Form of 2023 Common Warrant (incorporated by reference to Exhibit 4.2 to the Form 8-K filed by the issuer on July 31, 2023: https://www.sec.gov/Archives/edgar/data/1560258/000119380523001031/e618813_ex4-2.htm Form of 2024 Pre-funded Warrant (incorporated by reference to Exhibit 4.3 to the Form 8-K filed by the issuer on June 3, 2024: https://www.sec.gov/Archives/edgar/data/1560258/000119380524000740/e663679_ex4-3.htm Form of 2024 Common Warrant (incorporated by reference to Exhibit 4.2 to the Form 8-K filed by the issuer on June 3, 2024: https://www.sec.gov/Archives/edgar/data/1560258/000119380524000740/e663679_ex4-2.htm Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on December 7, 2023): https://www.sec.gov/Archives/edgar/data/1560258/000090883423000171/13g_theofolisex.htm

primary_doc.xml